← Leaderboards
John Damon Chodera
Sloan-Kettering Inst Can Research
$68,114,760
Attributed
$68,114,760
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $132.4M · FY2017–25$200M$150M$100M$50M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$157,960,611 · 13
By mechanism
U19$155,052,037 · 11
R01$1,831,454 · 1
R35$1,077,120 · 1
Top collaborators
- Alpha Albert Lee3 shared
- Peter Sjã2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Nikolaus Schultz$13,183,744
- Sohrab P Shah$4,881,319
- Raajit Rampal$5,822,249
- Vinod P Balachandran$5,168,008
- Alpha Albert Lee$0
Others in their field
Other Emerging Leaders on “Structure”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,827,589
- Mark Marino · Venturewell$48,913,644
Research focus
StructureDrug DiscoveryDesignGenerationsPharmaceutical PreparationsScreeningLeadBaseCostFree EnergySmall MoleculeLead OptimizationLigandsResistanceDrug ResistanceComplexStructural BiologyBindingViralToxic EffectMutationProgramsInnovationProteins
Grant awards (22)
AI-driven Structure-enabled Antiviral Platform (ASAP)$21,643,949
U19 · FY2025 · AI · contact PI
Teaching free energy calculations to learn$538,560
R35 · FY2025 · GM · contact PI
Teaching free energy calculations to learn$538,560
R35 · FY2024 · GM · contact PI
Lead optimization$528,000
U19 · FY2024 · AI · contact PI
AI-driven Structure-enabled Antiviral Platform (ASAP)$528,000
U19 · FY2024 · AI · contact PI
AI-driven Structure-enabled Antiviral Platform (ASAP)$67,673,902
U19 · FY2022 · AI · contact PI
Lead optimization$24,538,508
U19 · FY2022 · AI · contact PI
Fragment-to-lead and target validation$8,477,219
U19 · FY2022 · AI · contact PI
Administrative Core$7,107,143
U19 · FY2022 · AI · contact PI
Antiviral Efficacy and Resistance Core$6,599,276
U19 · FY2022 · AI · contact PI
Target enablement$6,545,783
U19 · FY2022 · AI · contact PI
Data Infrastructure Core$3,812,100
U19 · FY2022 · AI · contact PI
Covalent targeting strategies$2,861,620
U19 · FY2022 · AI · contact PI
Antiviral targeting to suppress drug resistance$2,132,587
U19 · FY2022 · AI · contact PI
Biochemical Assay Core$1,315,250
U19 · FY2022 · AI · contact PI
Structural Biology Core$1,288,700
U19 · FY2022 · AI · contact PI
The role of reorganization energy in achieving selective kinase inhibition$352,465
R01 · FY2021 · GM · contact PI
The role of reorganization energy in achieving selective kinase inhibition$352,465
R01 · FY2020 · GM · contact PI
The role of reorganization energy in achieving selective kinase inhibition$352,465
R01 · FY2019 · GM · contact PI
The role of reorganization energy in achieving selective kinase inhibition$336,961
R01 · FY2018 · GM · contact PI
The role of reorganization energy in achieving selective kinase inhibition"$99,745
R01 · FY2018 · GM · contact PI
The role of reorganization energy in achieving selective kinase inhibition$337,353
R01 · FY2017 · GM · contact PI